EP Patent

EP0502575A1 — Substituted 1-(2H)-isoquinolinones

Assigned to Merck and Co Inc · Expires 1992-09-09 · 34y expired

What this patent protects

Substituted 1-(2H)-isoquinolinones of the structural formula: <CHEM> are angiotensin II antagonists which are useful in the treatment of hypertension and congestive heart failure.

USPTO Abstract

Substituted 1-(2H)-isoquinolinones of the structural formula: <CHEM> are angiotensin II antagonists which are useful in the treatment of hypertension and congestive heart failure.

Drugs covered by this patent

Patent Metadata

Patent number
EP0502575A1
Jurisdiction
EP
Classification
—
Expires
1992-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.